REGENCY

By Freely Filtered - Last Updated: April 22, 2025

Freely Filtered discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.

Post Tags:lupus nephritis
Advertisement
Advertisement
Latest News

May 19, 2025